Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Am J Med

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    January 2018
  1. LEVIN SN, Lyons JL
    Infections of the Nervous System.
    Am J Med. 2018;131:25-32.
    PubMed     Text format     Abstract available


    December 2017
  2. MELLONI C, Dunning A, Granger CB, Thomas L, et al
    Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.
    Am J Med. 2017;130:1440-1448.
    PubMed     Text format     Abstract available


    November 2017
  3. NAZZAL S, Hijazi B, Khalila L, Blum A, et al
    Diagonal Earlobe Crease (Frank's Sign): A Predictor of Cerebral Vascular Events.
    Am J Med. 2017;130:1324.
    PubMed     Text format     Abstract available


    September 2017
  4. FANIKOS J, Burnett AE, Mahan CE, Dobesh PP, et al
    Renal Function Considerations for Stroke Prevention in Atrial Fibrillation.
    Am J Med. 2017;130:1015-1023.
    PubMed     Text format     Abstract available


    July 2017
  5. POTPARA TS, Lip GYH, Blomstrom-Lundqvist C, Chiang CE, et al
    Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal.
    Am J Med. 2017;130:773-779.
    PubMed     Text format     Abstract available


    June 2017
  6. BANGALORE S, Toklu B, Gianos E, Schwartzbard A, et al
    Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Am J Med. 2017;130:707-719.
    PubMed     Text format     Abstract available


    April 2017
  7. RENDA G, Ricci F, De Caterina R
    Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis.
    Am J Med. 2017;130:457-461.
    PubMed     Text format     Abstract available


    March 2017
  8. DALEN JE, Alpert JS
    Silent Atrial Fibrillation and Cryptogenic Strokes.
    Am J Med. 2017;130:264-267.
    PubMed     Text format     Abstract available


  9. BARBARYAN A, Bailuc S, Raqeem MW, Kak M, et al
    Wake-Up Call: Pulmonary Arteriovenous Malformation.
    Am J Med. 2017;130:290-292.
    PubMed     Text format    


    February 2017
  10. MAZUREK M, Huisman MV, Lip GY
    Registries in Atrial Fibrillation: From Trials to Real-Life Clinical Practice.
    Am J Med. 2017;130:135-145.
    PubMed     Text format     Abstract available


    December 2016
  11. BIENER M, Giannitsis E, Kuhner M, Zelniker T, et al
    Prognostic value of high-sensitivity cardiac troponin T compared to riskscores in stable cardiovascular disease.
    Am J Med. 2016 Dec 20. pii: S0002-9343(16)31242.
    PubMed     Text format     Abstract available


  12. FAUCHIER L, Villejoubert O, Clementy N, Bernard A, et al
    Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Am J Med. 2016;129:1278-1287.
    PubMed     Text format     Abstract available


    November 2016
  13. DE SOUZA BRITO F, Mehta RH, Lopes RD, Harskamp RE, et al
    Non-Steroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery.
    Am J Med. 2016 Nov 22. pii: S0002-9343(16)31197.
    PubMed     Text format     Abstract available


  14. DALEN JE, Alpert JS
    Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Am J Med. 2016;129:1159-1162.
    PubMed     Text format     Abstract available


  15. BARRA ME, Fanikos J, Connors JM, Sylvester KW, et al
    Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
    Am J Med. 2016;129:1198-1204.
    PubMed     Text format     Abstract available


  16. EIKELBOOM J, Merli G
    Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  17. MILLING TJ JR, Kaatz S
    Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  18. VILLINES TC, Peacock WF
    Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


  19. MILLING TJ JR, Spyropoulos AC
    Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


    October 2016
  20. ALEXANDER GC, Iyer G, Lucas E, Lin D, et al
    Cardiovascular risks of exogenous testosterone use among men: A systematic review and meta-analysis.
    Am J Med. 2016 Oct 14. pii: S0002-9343(16)31024.
    PubMed     Text format     Abstract available


  21. RENDA G, Zimarino M, Ricci F, Piccini JP, et al
    Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Am J Med. 2016;129:1117-1123.
    PubMed     Text format     Abstract available


  22. PEREG D, Rozenbaum Z, Vorobeichik D, Shlomo N, et al
    Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke.
    Am J Med. 2016;129:1074-81.
    PubMed     Text format     Abstract available


  23. PROIETTI M, Lip GY
    Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF Trials.
    Am J Med. 2016;129:1110-6.
    PubMed     Text format     Abstract available


    May 2016
  24. RUFF CT, Ansell JE, Becker RC, Benjamin EJ, et al
    North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Am J Med. 2016;129.
    PubMed     Text format     Abstract available


    November 2015
  25. AVINA-ZUBIETA JA, Man A, Yurkovich M, Huang K, et al
    Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis.
    Am J Med. 2015 Nov 18. pii: S0002-9343(15)01051.
    PubMed     Text format     Abstract available


  26. LARSEN KS, Pottegard A, Lindegaard HM, Hallas J, et al
    Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic patients A Cohort Study.
    Am J Med. 2015 Nov 14. pii: S0002-9343(15)01047.
    PubMed     Text format     Abstract available


    October 2015
  27. CAVENDER MA, Scirica BM, Raz I, Steg PG, et al
    Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
    Am J Med. 2015 Oct 30. pii: S0002-9343(15)01017.
    PubMed     Text format     Abstract available


  28. CHAUHAN V
    Hypothyroidism was 300% More Frequent than Hyperthyroidism in Patients with Atrial Fibrillation Enrolled Over 10 Years.
    Am J Med. 2015;128:e51.
    PubMed     Text format    


    September 2015
  29. RENDA G, di Nicola M, De Caterina R
    Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Am J Med. 2015;128:1007-14.
    PubMed     Text format     Abstract available


  30. ARGULIAN E, Conen D, Messerli FH
    Misconceptions and Facts About Atrial Fibrillation.
    Am J Med. 2015;128:938-42.
    PubMed     Text format     Abstract available


    August 2015
  31. MOHSENIN V
    Obstructive sleep apnea: a new preventive and therapeutic target for stroke: a new kid on the block.
    Am J Med. 2015;128:811-6.
    PubMed     Text format     Abstract available


    July 2015
  32. CAMERON SJ, Laskurain E, Holcman K, Richeson JF, et al
    Treacherous Travelers: Emboli.
    Am J Med. 2015;128:695-8.
    PubMed     Text format    


    June 2015
  33. BANGALORE S, Ogedegbe G, Gyamfi J, Guo Y, et al
    Outcomes with Angiotensin Converting Enzyme Inhibitors versus Other Antihypertensive Agents in Hypertensive Blacks.
    Am J Med. 2015 Jun 10. pii: S0002-9343(15)00445.
    PubMed     Text format     Abstract available


  34. HSU JC, Chan PS, Tang F, Maddox TM, et al
    Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Am J Med. 2015;128:654.
    PubMed     Text format     Abstract available


    April 2015
  35. KORNELIUS E, Chiou JY, Yang YS, Lu YL, et al
    The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes.
    Am J Med. 2015 Apr 20. pii: S0002-9343(15)00316.
    PubMed     Text format     Abstract available


    March 2015
  36. HOWARD VJ, Tanner RM, Anderson A, Irvin MR, et al
    Apparent Treatment-Resistant Hypertension among Individuals with History of Stroke or Transient Ischemic Attack.
    Am J Med. 2015 Mar 10. pii: S0002-9343(15)00179.
    PubMed     Text format     Abstract available


    February 2015
  37. SALIBA W, Barnett-Griness O, Elias M, Rennert G, et al
    The association between red cell distribution width and stroke in patients with atrial fibrillation.
    Am J Med. 2015;128:192.
    PubMed     Text format     Abstract available


    October 2014
  38. BAVRY AA, Gong Y, Handberg EM, Cooper-DeHoff RM, et al
    Impact of Aspirin According to Type of Stable Coronary Artery Disease: Insights from a Large International Cohort.
    Am J Med. 2014 Oct 15. pii: S0002-9343(14)00907.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: